These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 8872802

  • 1. The role of isoprenoids in vascular smooth muscle: potential benefits of statins unrelated to cholesterol lowering.
    Hughes AD.
    J Hum Hypertens; 1996 Jun; 10(6):387-90. PubMed ID: 8872802
    [Abstract] [Full Text] [Related]

  • 2. Pleiotropic effects of statins in atherosclerosis and diabetes.
    Bellosta S, Ferri N, Arnaboldi L, Bernini F, Paoletti R, Corsini A.
    Diabetes Care; 2000 Apr; 23 Suppl 2():B72-8. PubMed ID: 10860194
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasion.
    Turner NA, Midgley L, O'Regan DJ, Porter KE.
    J Cardiovasc Pharmacol; 2007 Oct; 50(4):458-61. PubMed ID: 18049315
    [Abstract] [Full Text] [Related]

  • 4. Non-lipid-related effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    Corsini A, Bernini F, Quarato P, Donetti E, Bellosta S, Fumagalli R, Paoletti R, Soma VM.
    Cardiology; 1996 Oct; 87(6):458-68. PubMed ID: 8904671
    [Abstract] [Full Text] [Related]

  • 5. Non-lipid-related effects of statins.
    Bellosta S, Ferri N, Bernini F, Paoletti R, Corsini A.
    Ann Med; 2000 Apr; 32(3):164-76. PubMed ID: 10821323
    [Abstract] [Full Text] [Related]

  • 6. [Cardiovascular pharmacology (VIII). The role of HMG CoA reductase inhibitors in the current treatment of hyperlipidemias].
    Carmena R.
    Rev Esp Cardiol; 1995 Jan; 48(1):59-65. PubMed ID: 7878284
    [No Abstract] [Full Text] [Related]

  • 7. Pathogenesis of atherosclerosis and the role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    Corsini A, Raiteri M, Soma MR, Bernini F, Fumagalli R, Paoletti R.
    Am J Cardiol; 1995 Jul 13; 76(2):21A-28A. PubMed ID: 7604791
    [Abstract] [Full Text] [Related]

  • 8. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia.
    Hsu I, Spinler SA, Johnson NE.
    Ann Pharmacother; 1995 Jul 13; 29(7-8):743-59. PubMed ID: 8520093
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors; comparison with other human cell types.
    Nègre-Aminou P, van Vliet AK, van Erck M, van Thiel GC, van Leeuwen RE, Cohen LH.
    Biochim Biophys Acta; 1997 Apr 21; 1345(3):259-68. PubMed ID: 9150246
    [Abstract] [Full Text] [Related]

  • 10. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP.
    Am J Geriatr Pharmacother; 2007 Sep 21; 5(3):185-94. PubMed ID: 17996658
    [Abstract] [Full Text] [Related]

  • 11. Potential risk of myopathy by HMG-CoA reductase inhibitors: a comparison of pravastatin and simvastatin effects on membrane electrical properties of rat skeletal muscle fibers.
    Pierno S, De Luca A, Tricarico D, Roselli A, Natuzzi F, Ferrannini E, Laico M, Camerino DC.
    J Pharmacol Exp Ther; 1995 Dec 21; 275(3):1490-6. PubMed ID: 8531120
    [Abstract] [Full Text] [Related]

  • 12. Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages.
    Luan Z, Chase AJ, Newby AC.
    Arterioscler Thromb Vasc Biol; 2003 May 01; 23(5):769-75. PubMed ID: 12663370
    [Abstract] [Full Text] [Related]

  • 13. [Statins have other beneficial properties besides their cholesterol lowering effect].
    Eriksson M.
    Lakartidningen; 1998 Aug 26; 95(35):3670-2. PubMed ID: 9748780
    [Abstract] [Full Text] [Related]

  • 14. Direct effects of statins on the vascular wall.
    Corsini A, Pazzucconi F, Arnaboldi L, Pfister P, Fumagalli R, Paoletti R, Sirtori CR.
    J Cardiovasc Pharmacol; 1998 May 26; 31(5):773-8. PubMed ID: 9593078
    [Abstract] [Full Text] [Related]

  • 15. Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase.
    Corsini A, Mazzotti M, Raiteri M, Soma MR, Gabbiani G, Fumagalli R, Paoletti R.
    Atherosclerosis; 1993 Jun 26; 101(1):117-25. PubMed ID: 8216498
    [Abstract] [Full Text] [Related]

  • 16. RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductase.
    Amin D, Rutledge RZ, Needle SN, Galczenski HF, Neuenschwander K, Scotese AC, Maguire MP, Bush RC, Hele DJ, Bilder GE, Perrone MH.
    J Pharmacol Exp Ther; 1997 May 26; 281(2):746-52. PubMed ID: 9152381
    [Abstract] [Full Text] [Related]

  • 17. [Anti-atherosclerotic actions of HMG-CoA reductase inhibitors].
    Gmiński J, Wojakowski W.
    Przegl Lek; 1997 May 26; 54(11):782-7. PubMed ID: 9501689
    [Abstract] [Full Text] [Related]

  • 18. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
    Davis HR, Pula KK, Alton KB, Burrier RE, Watkins RW.
    Metabolism; 2001 Oct 26; 50(10):1234-41. PubMed ID: 11586500
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological profile of a novel synthetic inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
    Aoki T, Nishimura H, Nakagawa S, Kojima J, Suzuki H, Tamaki T, Wada Y, Yokoo N, Sato F, Kimata H, Kitahara M, Toyoda K, Sakashita M, Saito Y.
    Arzneimittelforschung; 1997 Aug 26; 47(8):904-9. PubMed ID: 9296275
    [Abstract] [Full Text] [Related]

  • 20. Fluvastatin and lovastatin but not pravastatin induce neuroglial differentiation in human mesenchymal stem cells.
    Lee OK, Ko YC, Kuo TK, Chou SH, Li HJ, Chen WM, Chen TH, Su Y.
    J Cell Biochem; 2004 Nov 15; 93(5):917-28. PubMed ID: 15389871
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.